492 related articles for article (PubMed ID: 36553489)
1. In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations.
Psatha N; Paschoudi K; Papadopoulou A; Yannaki E
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553489
[TBL] [Abstract][Full Text] [Related]
2. Gene editing and CRISPR in the clinic: current and future perspectives.
Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
4. Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System.
Mussolino C; Alzubi J; Pennucci V; Turchiano G; Cathomen T
Hum Gene Ther; 2017 Nov; 28(11):1105-1115. PubMed ID: 28806883
[TBL] [Abstract][Full Text] [Related]
5. Delivery Approaches for Therapeutic Genome Editing and Challenges.
Ates I; Rathbone T; Stuart C; Bridges PH; Cottle RN
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32977396
[TBL] [Abstract][Full Text] [Related]
6. Genome Editing: Moving Toward a New Era of Innovation, Development, and Approval.
Bachtarzi H
Hum Gene Ther; 2023 Mar; 34(5-6):171-176. PubMed ID: 36772799
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases.
Schreurs J; Sacchetto C; Colpaert RMW; Vitiello L; Rampazzo A; Calore M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681646
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Genome Editing as a Therapeutic Approach.
Ho BX; Loh SJH; Chan WK; Soh BS
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213032
[TBL] [Abstract][Full Text] [Related]
9. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
Dever DP; Porteus MH
Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
[TBL] [Abstract][Full Text] [Related]
10. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
[TBL] [Abstract][Full Text] [Related]
11. Using Gene Editing Approaches to Fine-Tune the Immune System.
Pavlovic K; Tristán-Manzano M; Maldonado-Pérez N; Cortijo-Gutierrez M; Sánchez-Hernández S; Justicia-Lirio P; Carmona MD; Herrera C; Martin F; Benabdellah K
Front Immunol; 2020; 11():570672. PubMed ID: 33117361
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus vectors in hematopoietic stem cell genome editing.
Li C; Lieber A
FEBS Lett; 2019 Dec; 593(24):3623-3648. PubMed ID: 31705806
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in stem cells and gene editing: Drug discovery and therapeutics.
Bayarsaikhan D; Bayarsaikhan G; Lee B
Prog Mol Biol Transl Sci; 2021; 181():231-269. PubMed ID: 34127195
[TBL] [Abstract][Full Text] [Related]
14. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
[TBL] [Abstract][Full Text] [Related]
15. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.
Lee BC; Lozano RJ; Dunbar CE
Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic editing of hepatocyte genome in vivo.
Ruiz de Galarreta M; Lujambio A
J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
[TBL] [Abstract][Full Text] [Related]
17. Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPR.
Shamshirgaran Y; Liu J; Sumer H; Verma PJ; Taheri-Ghahfarokhi A
Methods Mol Biol; 2022; 2495():29-46. PubMed ID: 35696026
[TBL] [Abstract][Full Text] [Related]
18. Research on genodermatoses using novel genome-editing tools.
Lehmann J; Seebode C; Emmert S
J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
[TBL] [Abstract][Full Text] [Related]
19. Non-viral strategies for delivering genome editing enzymes.
Li J; Røise JJ; He M; Das R; Murthy N
Adv Drug Deliv Rev; 2021 Jan; 168():99-117. PubMed ID: 32931860
[TBL] [Abstract][Full Text] [Related]
20. Engineering Delivery Vehicles for Genome Editing.
Nelson CE; Gersbach CA
Annu Rev Chem Biomol Eng; 2016 Jun; 7():637-62. PubMed ID: 27146557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
